Sabra Healthcare REIT saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase from 68 to 79.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the trailing 52 weeks stacks up against all the other stocks in our database.
History reveals that the top-performing stocks typically have an RS Rating of above 80 as they launch their biggest climbs. See if Sabra Healthcare REIT can continue to rebound and clear that threshold.
Sabra Healthcare REIT is trading within a buying range after moving past an 18.99 entry in a flat base. Once a stock moves 5% or higher beyond the initial entry, it's considered out of a proper buying area.
The company posted 3% EPS growth last quarter. Sales rose 7%.
Sabra Healthcare REIT earns the No. 6 rank among its peers in the Finance-Property REITs industry group. CareTrust REIT, Postal Realty Trust Cl A and NetSTREIT are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
